CompletedPhase 2NCT02346461
An Open Label Phase 2 Study of ManNAc in Subjects With GNE Myopathy
Studying GNE myopathy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Human Genome Research Institute (NHGRI)
- Principal Investigator
- Nuria Carrillo, M.D., M.DNational Human Genome Research Institute (NHGRI)
- Intervention
- ManNAc(drug)
- Enrollment
- 12 enrolled
- Eligibility
- 18-60 years · All sexes
- Timeline
- 2015 – 2018
Study locations (1)
- National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Collaborators
National Center for Advancing Translational Sciences (NCATS)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02346461 on ClinicalTrials.govOther trials for GNE myopathy
Additional recruiting or active studies for the same condition.